In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Miguel MesquitaGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0001-5927-790X Maria PiresGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.
Sara ViolanteGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0003-2124-5712 Jamil Zola KitokoGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0003-0973-5460 Martim CostaGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.
Sonia Trikha RastogiGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0002-2333-7170 Rui MartinsGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0001-8106-6324 Silvia CardosoGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0003-4639-698X Manuel TanqueiroGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.
Ana FigueiredoGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0001-9075-2238 Nelli Blank-SteinDevelopmental Biology of the Immune System, Life & Medical Sciences (LIMES) Institute, University of Bonn; 53115 Bonn, Germany.ORCID 0000-0003-2258-736X Elvira MassDevelopmental Biology of the Immune System, Life & Medical Sciences (LIMES) Institute, University of Bonn; 53115 Bonn, Germany.ORCID 0000-0003-2318-2356 Bindu PaulDepartment of Physiology, Pharmacology & Therapeutics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.ORCID 0000-0002-1862-6103 Moises MalloGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0002-9744-0912 Elisa JenthoGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0002-4790-7860 Miguel P SoaresGulbenkian Institute for Molecular Medicine (GIMM), Avenida Professor Egas Moniz - 1649-035 Lisboa, Portugal.ORCID 0000-0002-9314-4833 Funding
Thorase Regulation of the Actions of CocaineP50DA044123 · NIDA · JOHNS HOPKINS UNIVERSITY · PI BARABAN, JAY M · 2018 to 2022
$9.0MNeuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signalingR01AG071512 · NIA · JOHNS HOPKINS UNIVERSITY · PI Bindu Paul · 2022 to 2026
$3.4MRole of sulfhydration on the functions of the microtubule associated protein, TauR21AG073684 · NIA · JOHNS HOPKINS UNIVERSITY · PI PAUL, BINDU · 2021 to 2022
$450kNIA NIH HHS R01 AG071512NIA NIH HHS R21 AG073684NIDA NIH HHS P50 DA044123
6 · The paper itselfAbstract
Iron deficiency anemia affects one-third of the global human population. Paradoxically, the daily iron required to fuel the production red blood cell (RBC) and prevent anemia is provided through its recycling from senescent RBC. This is achieved by splenic red pulp macrophages (RPM) that extract iron from the heme groups of hemoglobin (Hb). How these professional erythrophagocytic macrophages prevent intracellular iron flux from inducing cell death via ferroptosis is unknown. Here we show that SPI-C, the master transcriptional regulator of the erythrophagocytic lineage, orchestrates two redundant anti-ferroptosis pathways. One supports glutathione synthesis, via NF-E2-related factor 2 (NRF2), and the other relies on bilirubin production by biliverdin reductase A (BVRA). Genetic ablation of both pathways, but not either alone, sensitizes erythrophagocytic macrophages to ferroptosis, depletes RPM and increases the severity of iron deficiency anemia in mice. These findings reveal a central physiologic role of ferroptosis in the control of macrophage function, iron homeostasis and iron-deficiency anemia.
Identifiers
PMID42395532
PMCPMC13320925
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390